Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis.
The effect of cyclosporin (CS) was assessed in Sprague-Dawley rats with puromycin aminonucleoside (PA) nephrosis induced by a single intraperitoneal injection of PA. Three groups of rats were injected intraperitoneally with CS (10 mg/kg body weight) daily, beginning 1 day before PA administration, or 5 or 10 days after PA administration, for 10 days. CS significantly reduced proteinuria in rats with PA nephrosis in comparison with untreated nephrotic controls. After discontinuation of the CS treatment, proteinuria gradually increased, reaching values similar to those in control nephrotic rats. CS pretreatment did not prevent the induction of PA-induced nephrotic syndrome. Light microscopy and assessment of anionic sites in the glomerular basement membrane revealed no differences between normal rats, nephrotic controls, and CS-treated rats. These results show that CS can reduce proteinuria in PA nephrosis, but cannot ameliorate the glomerular changes.
Kokui
K
K
Department of Pediatrics, Kobe University School of Medicine, Japan.
Yoshikawa
N
N
Nakamura
H
H
Itoh
H
H
D000818:Animals; D000838:Anions / Q000378:metabolism; D001485:Basement Membrane / Q000378:metabolism; D003401:Creatine / Q000097:blood; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use*; D007668:Kidney / Q000473:pathology; D007678:Kidney Glomerulus / Q000378:metabolism; D008297:Male; D009401:Nephrosis / Q000097:blood / Q000139:chemically induced / Q000150:complications*; D011507:Proteinuria / Q000188:drug therapy* / Q000209:etiology / Q000652:urine; D011692:Puromycin Aminonucleoside; D051381:Rats; D011919:Rats, Inbred Strains
D000838:Anions; D011692:Puromycin Aminonucleoside; D016572:Cyclosporine; D003401:Creatine